Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandran, P. K.
Right arrow Articles by Kirkpatrick, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandran, P. K.
Right arrow Articles by Kirkpatrick, B.

Journal of the American Society of Nephrology, Vol 4, 1199-1204, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Patient survival on PAN/AN69 membrane hemodialysis: a ten-year analysis

PK Chandran, R Liggett and B Kirkpatrick
University of Iowa College of Medicine, Nephrology Clinic, Des Moines.

Survival characteristics over a 10-yr period of 352 patients on hemodialysis (HD) with polyacrylonitrile membranes in a single center were retrospectively analyzed and compared with national data collected by the U.S. Renal Data System (USRDS). Only those patients who stayed on HD for longer than 3 months were included. Any outcome other than death was considered as lost to follow-up. The number of expected deaths in the entire patient population according to the USRDS data base was 203, whereas the observed actual rate was only 132, reaching high statistical significance. Several subgroups of patients, stratified on the basis of age and time on starting HD, diabetes mellitus as the cause of original renal disease, etc., also exhibited significantly better survival. HD with a biocompatible membrane, providing adequate removal of low- as well as "middle"-molecular-weight uremic toxins, may be one important explanation for improved survival.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
T. Boure and R. Vanholder
Which dialyser membrane to choose?
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 293 - 296.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673